[PDF] Top 20 Nuevos formatos en el periodismo deportivo

... reviewed economic analyses of therapies for NSCLC identified by a MEDLINE, CRD, and HEED data- base search, using a disease-specific medical subject heading term (“lung neoplasms”) and subheading ...this ... See full document

... independent review and defined as the length of time from randomization to disease progression or death from any cause) was significantly prolonged with erlotinib versus placebo (HR ... See full document

... a systematic literature review, network meta-analyses were performed to obtain hazard ratios for progression-free survival (PFS) and overall survival (OS) relative to gemcitabine + cisplatin (induction ... See full document

... of non-small-cell lung cancer is dependent on disease ...locally advanced disease, the importance of finding therapeutic schemes that may benefit this population is ...This ... See full document

... on histologic type, only patients with adenocarcinomas were randomized. Nonetheless, all eligible patients were included in economic analysis. According to our pre-specified protocol, the primary endpoint of the ... See full document

... this review found an increasing number of published cost-effectiveness analyses of targeted therapies in the treatment of NSCLC in the later years analyzed, eg, 2015 – 2019, as compared with the earlier years ... See full document

... the First Affiliated Hospital of Xi’an Jiaotong University and written informed consent was obtained from each ...with advanced lung adenocarcinoma and with EGFR-sensitive mutation between March 2012 ... See full document

... study. First, about half of the eligible patients had no tumor response assessment because of early treatment ...social economic status on hospital costs for nonchemotherapy drugs and nondrug care due to ... See full document

... standard treatments, aimed to assess the maximum tolerated dose of ...with advanced ALK- positive ...Response Evaluation Criteria in Solid ... See full document

... for first-round PCR, and use of cDNA as the template for PCR instead of gDNA. Universe High-Fidelity Hot Start DNA Polymerase (Biotool, Houston, TX, USA) was used as the PCR enzyme. DGGE analysis was performed on ... See full document

... Eighteen studies presenting data of 5,881 patients for NLR and OS in lung cancer patients. In both studies, the elevated NLR were expected to have shorter OS with a pooled HR of 1.23 (95% CI: 1.17–1.29; P ... See full document

... in first-line treatment of locally advanced or metastatic NSCLC patients with adenocarcinoma who have never or seldom smoked ...in non-smokers seemed higher than that in smokers, the result ... See full document

... NSCLC, non-small cell lung cancer; p85/p110, phosphoinositide 3-kinase; PD-1, programmed cell death 1; PTeN, phosphatase and tensin homolog; RAF, rapidly accelerated ... See full document

... with non-squamous his- tology, but failed for patients with squamous ...with advanced non-squamous NSCLC as a first-line regimen by the European Medicines Agency in April 2008 and by ... See full document

... after first-line chemotherapy is completed and before disease progression ...the maintenance therapy being tested would be randomized with a placebo, and mandated to be used in the placebo group upon ... See full document

... Our findings must be interpreted cautiously since all included studies have high risk of bias, especially perfor- mance and detection bias. These systematic errors could overestimate or underestimate the ... See full document

... Adverse effects induced by afatinib can cause devastating quality of life issues for patients undergoing afatinib treatment. We conducted a study to evaluate the prophylactic efficacy of TJ-14 (hangeshashin-to, a ... See full document

... for systematic reviews and meta-analyses (PRISMA) flow chart was adapted to de- pict the study selection process ...or non- randomized controlled trials comparing RATS to ... See full document

... competitive small molecule inhibitor of ALK with an IC50 of ...with advanced malignancies (ex- cluding leukemia) ...with advanced malignancies [95]. Patients (pts) with advanced solid tu- mors ... See full document

... assessing maintenance therapy in elderly patients with advanced NSCLC were ...Single-agent maintenance therapy in elderly patients significantly improved PFS (hazard ratio [HR] ...doublet ... See full document